Restoring Ovarian Function With Human Placenta-Derived Mesenchymal Stem Cells in Autoimmune-Induced Premature Ovarian Failure Mice Mediated by Treg Cells and Associated Cytokines

Abstract

Regulatory T (Treg) cells play a key role in the regulation of autoimmunity and transplantation. Human placenta-derived mesenchymal stem cell (hPMSC) transplantation has a potential to restore ovarian dysfunction associated with premature ovarian failure (POF), while the exact function of the Treg cells in the transplantation still needs to be further investigated. In this study, hPMSCs were intravenously injected into POF mice following zona pellucida glycoprotein 3 (pZP3) treatment. Ovarian function was measured by analyzing estrous cycle, folliculogenesis, and hormone secretion, also, with the detection of apoptotic granular cells (GCs) in ovarian tissues. To determine whether immune response is involved in the regulation of ovarian function change, the population of Treg cell populations and expression of associated cytokines, for example, transforming growth factor β (TGF-β) and interferon γ (IFN-γ) were measured. After hPMSCs transplantation, the injured ovarian function is significantly improved. Also, the pZP3-treatment-induced apoptotic GCs were significantly decreased as compared with the POF mice. The transplantation of hPMSCs significantly increased the population of Treg cells which was inhibited by pZP3 treatment. The decrease in TGF-β and increase in IFN-γ in serum caused by pZP3 treatment have been reversed following hPMSCs transplantation. These findings strongly suggest that the recovery of ovarian function in POF mice is mediated via the regulation of Treg cells and production of associated cytokines following hPMSCs transplantation.

Keywords

pZP3 premature ovarian failure human placenta-derived mesenchymal stem cell transplantation regulatory T cells cytokine apoptosis

Get full access to this article

View all access options for this article.

References

Vujović

Ivović

Tancić-Gajić

. Premature ovarian failure. Srp Arh Celok Lek. 2012;140(11-12):806–811.

McGuire

Bowden

Engel

Ahn

Kovanci

Rajkovic

. Genomic analysis using high-resolution single-nucleotide polymorphism arrays reveals novel microdeletions associated with premature ovarian failure. Fertil Steril. 2011;95(5):1595–1600.

Rebar

. Premature ovarian failure. Obstet gynecol. 2009;113(6):1355–1363.

Jagarlamudi

Reddy

Adhikari

Liu

. Genetically modified mouse models for premature ovarian failure (POF). Mol cell endocrinol. 2010;315(1-2):1–10.

Tung

. Immunologic basis of reproductive failure. Monogr Pathol. 1991;(33):308–333.

Feng

Huang

. ZP3 peptides administered orally suppress murine experimental autoimmune ovarian disease. J Reprod Immunol. 2007;75(1):40–47.

Setiady

Samy

Tung

KSK

. Maternal autoantibody triggers de novo t cell-mediated neonatal autoimmune disease. J Immunol. 2003;170(9):4656–4664.

Luan

Wang

Lin

. Human placenta-derived mesenchymal stem cells suppress T cell proliferation and support the culture expansion of cord blood CD34(+) cells: a comparison with human bone marrow-derived mesenchymal stem cells. Tissue Cell. 2013;45(1):32–38.

Chen

Inobe

Marks

Gonnella

Kuchroo

Weiner

. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature. 1995;376(6536):177–180.

10.

Kristensen

Andersen

Clement

Franks

Hardy

Andersen

. Expression of TGF-beta superfamily growth factors, their receptors, the associated SMADs and antagonists in five isolated size-matched populations of pre-antral follicles from normal human ovaries. Mol Hum Reprod. 2014;20(4):293–308.

11.

Visser

Schipper

Laven

Themmen

. Anti-mullerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 2012;8(6):331–341.

12.

Abd-Allah

Shalaby

Pasha

. Mechanistic action of mesenchymal stem cell injection in the treatment of chemically induced ovarian failure in rabbits. Cytotherapy. 2013;15(1):64–75.

13.

Takehara

Yabuuchi

Ezoe

. The restorative effects of adipose-derived mesenchymal stem cells on damaged ovarian function. Lab Invest. 2013;93(2):181–193.

14.

Lin

Martin

Xia

Gorham

. TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet. J Immunol. 2005;174(10):5950–5958.

15.

Nakanishi

Yoshimoto

Tsutsui

Okamura

. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev. 2001;12(1):53–72.

16.

Wang

Zhang

Wang

Zhang

Luan

. Expression and biological function of programmed death ligands in human placenta mesenchymal stem cells. Cell Biol Int. 2013;37(2):137–148.

17.

Park

Hwang

Han

. Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action. Diabetes Res Clin Pract. 2012;98(3):465–473.

18.

Chang

Choi

Ahn

. Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury. PLoS One. 2013;8(1):e52419.

19.

Xiao

Liu

Cheng

. Amniotic fluid stem cells prevent follicle atresia and rescue fertility of mice with premature ovarian failure induced by chemotherapy. PLoS One. 2014;9(9):e106538.

20.

Myers

Britt

Wreford

Ebling

Kerr

. Methods for quantifying follicular numbers within the mouse ovary. Reproduction (Cambridge, England). 2004;127(5):569–580.

21.

Stephens

Gray

Anderton

. CD4+CD25+ regulatory T cells limit the risk of autoimmune disease arising from T cell receptor crossreactivity. Proc Nati Acad Sci U S A. 2005;102(48):17418–17423.

22.

Takamizawa

Shibahara

Shibayama

Suzuki

. Detection of antizona pellucida antibodies in the sera from premature ovarian failure patients by a highly specific test. Fertil Steril. 2007;88(4):925–932.

23.

Bagavant

Adams

Terranova

. Autoimmune ovarian inflammation triggered by proinflammatory (Th1) T cells is compatible with normal ovarian function in mice. Biol Reprod. 1999;61(3):635–642.

24.

Kilic

Pinarli

Ozogul

Tasdemir

Naz Sarac

Delibasi

. Protection from cyclophosphamide-induced ovarian damage with bone marrow-derived mesenchymal stem cells during puberty. Gynecol Endocrinol. 2014;30(2):135–140.

25.

Liu

Huang

Zhang

. Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse model. Stem Cells Dev. 2014;23(13):1548–1557.

26.

Iorio

Castellucci

Ventriglia

. Ovarian toxicity: from environmental exposure to chemotherapy. Curr Pharm Des. 2014;20(34):5388–5397.

27.

Elfayomy

Almasry

El-Tarhouny

Eldomiaty

. Human umbilical cord blood-mesenchymal stem cells transplantation renovates the ovarian surface epithelium in a rat model of premature ovarian failure: Possible direct and indirect effects. Tissue & Cell. 2016;48(4):370–382.

28.

Sun

Wang

. Adipose-derived stem cells improved mouse ovary function after chemotherapy-induced ovary failure. Stem Cell Res Ther. 2013;4(4):80.

29.

Liu

Huang

Guo

Cheng

Zou

. CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure. Int J Med Sci. 2012;9(7):592–602.

30.

Luo

Garza

Hunt

Tung

. Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activation. J Clin Invest. 1993;92(5):2117–2123.

31.

Gonfloni

Di Tella

Caldarola

. Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death. Nat Med. 2009;15(10):1179–1185.

32.

Shelling

. Premature ovarian failure. Reproduction. 2010;140(5):633–641.

33.

Dang

Jin

Liu

Wang

. Human cord blood mononuclear cell transplantation for the treatment of premature ovarian failure in nude mice. Int J Clin Exp Med. 2015;8(3):4122–4127.

34.

Liu

Qin

Huang

Zhao

Wang

. Induction of estrogen-sensitive epithelial cells derived from human-induced pluripotent stem cells to repair ovarian function in a chemotherapy-induced mouse model of premature ovarian failure. DNA Cell Biol.2013;32(12):685–698.

35.

Haughian

Ginther

Diaz

Wiltbank

. Gonadotropin-releasing hormone, estradiol, and inhibin regulation of follicle-stimulating hormone and luteinizing hormone surges: implications for follicle emergence and selection in heifers. Biol Reprod. 2013;88(6):165.

36.

Lai

Wang

Dong

Zhang

. Skin-derived mesenchymal stem cells help restore function to ovaries in a premature ovarian failure mouse model. PLoS One. 2014;9(5):e98749.

37.

Kupcova Skalnikova

. Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie. 2013;95(12):2196–2211.

38.

Maclaran

Panay

. Premature ovarian failure. J Fam Plann Reprod health care. 2011;37(1):35–42.

39.

Coulam

Stern

. Immunology of ovarian failure. Am J Reprod Immunol. 1991;25(4):169–174.

40.

Patel

Meyer

Greco

Corcoran

Bryan

Rameshwar

. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol. 2010;184(10):5885–5894.

41.

Chow

Johnson

Coy

Regan

Dow

. Mechanisms of immune suppression utilized by canine adipose and bone marrow-derived mesenchymal stem cells. Stem Cells Dev. 2016;26(5):374–389.

42.

Wan

Zhen

. Injury-activated transforming growth factor beta controls mobilization of mesenchymal stem cells for tissue remodeling. Stem Cells. 2012;30(11):2498–2511.

43.

Pangas

. Regulation of the ovarian reserve by members of the transforming growth factor beta family. Mol Reprod Dev. 2012;79(10):666–679.